secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kezar Life Sciences, Inc. (KZR)
CIK:        0001645666
Form:       8-K
Filed at:   2025-10-22T23:59:59+00:00
Accession:  0001628280-25-045871
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Kezar Life Sciences repays $6.3M in full, terminates Loan Agreement with Oxford Finance
--------------------------------------------------------------------------------

- Repaid $6.3M in full satisfaction of outstanding amount including accrued interest and exit fees.
- Loan and Security Agreement dated Nov 4, 2021 terminated; all liens and security interests released.
- Repayment made using cash on hand; no new debt incurred.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645666/000162828025045871/0001628280-25-045871-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645666/000162828025045871/kzr-20251020.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-045871

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer